Aaron G. Schmidt

2007–2025 年に発表

82
論文数
18,803
被引用数
54
h 指数
81
i10 指数

被引用数

Aaron G. Schmidt の年別被引用数1982 年: 被引用 2 件1990 年: 被引用 1 件1995 年: 被引用 1 件2004 年: 被引用 2 件2006 年: 被引用 1 件2008 年: 被引用 18 件2009 年: 被引用 8 件2010 年: 被引用 14 件2011 年: 被引用 13 件2012 年: 被引用 16 件2013 年: 被引用 18 件2014 年: 被引用 22 件2015 年: 被引用 11 件2016 年: 被引用 27 件2017 年: 被引用 35 件2018 年: 被引用 57 件2019 年: 被引用 169 件2020 年: 被引用 1,281 件2021 年: 被引用 2,587 件2022 年: 被引用 1,705 件2023 年: 被引用 585 件2024 年: 被引用 646 件2025 年: 被引用 262 件2026 年: 被引用 13 件1983〜1989 年は被引用が無いため表示していません1991〜1994 年は被引用が無いため表示していません1996〜2003 年は被引用が無いため表示していません2005 年は被引用が無いため表示していません2007 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,938 件、この内訳の 29.9%中国: 引用元論文 896 件、この内訳の 9.1%イギリス: 引用元論文 680 件、この内訳の 6.9%ドイツ: 引用元論文 421 件、この内訳の 4.3%イタリア: 引用元論文 358 件、この内訳の 3.7%フランス: 引用元論文 303 件、この内訳の 3.1%カナダ: 引用元論文 293 件、この内訳の 3%インド: 引用元論文 249 件、この内訳の 2.5%オーストラリア: 引用元論文 243 件、この内訳の 2.5%日本: 引用元論文 240 件、この内訳の 2.4%オランダ: 引用元論文 220 件、この内訳の 2.2%スイス: 引用元論文 204 件、この内訳の 2.1%
0%29.9%その他 28.3%

分野

  • Medicine78.1%
  • Biochemistry, Genetics and Molecular Biology8.7%
  • Immunology and Microbiology7.9%
  • Neuroscience0.9%
  • Agricultural and Biological Sciences0.8%
  • Mathematics0.7%
  • その他2.9%

トピック

  • SARS-CoV-2 and COVID-19 Research19.6%
  • COVID-19 Clinical Research Studies13.8%
  • Long-Term Effects of COVID-194.4%
  • SARS-CoV-2 detection and testing3.4%
  • vaccines and immunoinformatics approaches2.7%
  • Animal Virus Infections Studies2.5%
  • その他53.6%

共著者

全論文

検索で開く
  1. SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sandra L. Leibel, Joyce Jose, Kevin D. Corbett, Andrew B. Ward, Aaron F. Carlin, Jeffrey D. Esko - Cell 2020 被引用: 1,209

  2. SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Avinash Waghray, Vanessa Mitsialis, Daniel F. Dwyer, Kathleen M. Buchheit, Joshua A. Boyce, Nora A. Barrett, Tanya M. Laidlaw, Shaina L. Carroll, Lucrezia Colonna, Victor Tkachev, Christopher W. Peterson, Alison Yu, Hengqi Zheng, Hannah P. Gideon, Caylin G. Winchell, Philana Ling Lin, Colin D. Bingle, Scott B. Snapper, Jonathan A. Kropski, Fabian J. Theis, Herbert B. Schiller, Laure‐Emmanuelle Zaragosi, Pascal Barbry, Alasdair Leslie, Hans‐Peter Kiem, JoAnne L. Flynn, Sarah M. Fortune, Bonnie Berger, Robert W. Finberg, Leslie S. Kean, Manuel Garber, Aaron G. Schmidt, Daniel Lingwood, Alex K. Shalek, José Ordovás-Montañés, Nicholas E. Banovich, Pascal Barbry, Alvis Brāzma, Tushar Desai, Thu Elizabeth Duong, Oliver Eickelberg, Christine S. Falk, Michael Farzan, Ian A. Glass, Muzlifah Haniffa, Péter Horváth, Deborah Hung, Naftali Kaminski, Mark A. Krasnow, Jonathan A. Kropski, Malte Kühnemund, Robert Lafyatis, Haeock Lee, Sylvie Leroy, Sten Linnarson, Joakim Lundeberg, Kerstin Meyer, Alexander Misharin, Martijn C. Nawijn, Marko Nikolić, José Ordovás-Montañés, Dana Pe’er, Joseph E. Powell, Stephen R. Quake, Jayaraj Rajagopal, Purushothama Rao Tata, Emma L. Rawlins, Aviv Regev, Paul A. Reyfman, Mauricio Rojas ほか 21 名 - Cell 2020 被引用: 2,494

  3. mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant

    著者: , , , , , , , , , , , , , , , , , - Cell 2022 被引用: 1,098

  4. Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responses

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Immunity 2022 被引用: 157

  5. Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ngoc L. Ly, Ashlin R. Michell, Yelizaveta Rassadkina, Kyra Seiger, Libera Sessa, Sally Shin, Nishant K. Singh, Weiwei Sun, Xiaoming Sun, Hannah Ticheli, Michael T. Waring, Alex Zhu, Galit Alter, Jonathan Z. Li, Daniel Lingwood, Aaron G. Schmidt, Mathias Lichterfeld, Bruce D. Walker, Xu G. Yu, Robert F. Padera, Shiv Pillai - Cell 2020 被引用: 784

  6. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laura L. Sutherland, David C. Montefiori, Robert J. Edwards, Kevin O. Saunders, Charlene McDanal, Giovanna E. Hernandez, Katayoun Mansouri, Robert E. Parks, Xiaozhi Lu, Blake M. Hauser, C. Todd DeMarco, Fangping Cai, Barney S. Graham, Kevin Wiehe, John R. Mascola, Gregory D. Sempowski, Hanné Andersen, Elizabeth Petzold, David R. Martinez, Peter D. Kwong, Victoria Gee-Lai, Megan Kopp, S. Gobeil, Victoria Stalls, Aja Sanzone, Wes Rountree, Barton F. Haynes, Mark G. Lewis, Priyamvada Acharya, Thomas H. Oguin, Chuancang Jiang, I‐Ting Teng, Andrew Foulger, Christopher W. Woods - Cell 2021 被引用: 334

  7. Rapid generation of potent antibodies by autonomous hypermutation in yeast

    著者: , , , , , , , , , , , , , , , , , - Nature Chemical Biology 2021 被引用: 134

  8. Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds

    著者: , , , , , , , , , , , , , , , , - Nature Communications 2024 被引用: 79

  9. Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Makda S. Gebre, Emily Hoffman, Catherine Jacob-Dolan, Marinela Kirilova, Zhenfeng Li, Zijin Lin, Shant H. Mahrokhian, Lori F. Maxfield, Felix Nampanya, Ramya Nityanandam, Joseph P. Nkolola, Shivani Patel, John D. Ventura, Kaylee Verrington, Huahua Wan, Laurent Pessaint, Alex Van Ry, Kelvin Blade, Amanda Strasbaugh, Mehtap Cabus, Renita Brown, Anthony Cook, Serge Zouantchangadou, Elyse Teow, Hanné Andersen, Mark G. Lewis, Yongfei Cai, Bing Chen, Aaron G. Schmidt, R. Keith Reeves, Ralph S. Baric, Douglas A. Lauffenburger, Galit Alter, Paul Stoffels, Mathai Mammen, Johan Van Hoof, Hanneke Schuitemaker, Dan H. Barouch - Nature 2020 被引用: 907

  10. Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality

    著者: , , , , , , , , , , , , , , , , , , - Cell 2020 被引用: 341

  11. Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew S. Azman, Galit Alter, Edward T. Ryan, Jason B. Harris, Richelle C. Charles - Science Immunology 2020 被引用: 691

  12. Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David Pépin, Michael S. Seaman, Dan H. Barouch, Bruce D. Walker, Xu G. Yu, Anjali J. Kaimal, Drucilla J. Roberts, Galit Alter - JAMA Network Open 2020 被引用: 439

  13. Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2021 被引用: 420

  14. Complex Antigens Drive Permissive Clonal Selection in Germinal Centers

    著者: , , , , , , , , - Immunity 2016 被引用: 329

  15. SARS-CoV-2 infection protects against rechallenge in rhesus macaques

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Frank Wegmann, Peter Abbink, Esther A. Bondzie, Gabriel Dagotto, Makda S. Gebre, Xuan He, Catherine Jacob-Dolan, Nicole Kordana, Zhenfeng Li, Michelle A. Lifton, Shant H. Mahrokhian, Lori F. Maxfield, Ramya Nityanandam, Joseph P. Nkolola, Aaron G. Schmidt, Andrew D. Miller, Ralph S. Baric, Galit Alter, Peter K. Sorger, Jacob D. Estes, Hanné Andersen, Mark G. Lewis, Dan H. Barouch - Science 2020 被引用: 926

  16. Antibodies to a Conserved Influenza Head Interface Epitope Protect by an IgG Subtype-Dependent Mechanism

    著者: , , , , , , , , , , , , , , , , , - Cell 2019 被引用: 207

  17. Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection

    著者: , , , , , , , , , , , , , , - Nature Immunology 2024 被引用: 42

  18. Distinct Early Serological Signatures Track with SARS-CoV-2 Survival

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Immunity 2020 被引用: 420

  19. Protein engineering strategies for rational immunogen design

    著者: , - npj Vaccines 2021 被引用: 70

  20. Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody

    著者: , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2017 被引用: 155

  21. Memory B Cells that Cross-React with Group 1 and Group 2 Influenza A Viruses Are Abundant in Adult Human Repertoires

    著者: , , , , , , , , , - Immunity 2018 被引用: 150

  22. Viral Receptor-Binding Site Antibodies with Diverse Germline Origins

    著者: , , , , , , , - Cell 2015 被引用: 193

  23. Influenza Antigen Engineering Focuses Immune Responses to a Subdominant but Broadly Protective Viral Epitope

    著者: , , , , , , , , , , - Cell Host & Microbe 2019 被引用: 174

  24. Ultrasensitive high-resolution profiling of early seroconversion in patients with COVID-19

    著者: , , , , , , , , , , , , , , , , , , - Nature Biomedical Engineering 2020 被引用: 150